Hims & Hers Health, Inc. income statement HIMS

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Hims & Hers Health, Inc. reported revenue of $2.3 billion, up 59.0% from the year before. Net income was $128.4 million, a profit margin of 5.5%. Operating income came to $105.6 million, an operating margin of 4.5%. Diluted earnings per share were $0.51. Over the twelve months ended Jun 30, 2026, revenue was $2.6 billion and the net loss was $142.0 million. Across the 5 fiscal years shown, revenue grew from $271.9 million in fiscal 2021 to $2.3 billion in fiscal 2025, about 71.4% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Revenue
2,578
+28.0%
2,348
+59.0%
1,477
+69.3%
872
+65.5%
527
+93.8%
272
—
Cost of revenue
814
+69.9%
614
+102.5%
303
+93.2%
157
+32.9%
118
+75.4%
67
—
Gross profit
1,764
+15.0%
1,733
+47.8%
1,173
+64.1%
715
+74.9%
409
+99.9%
204
—
Selling, general and administrative
1,386
+30.7%
1,192
+40.8%
847
+46.9%
576
+55.4%
371
+101.9%
184
+605.4%
26
Operating income
-155
-223.0%
106
+70.6%
62
+310.2%
-29
+57.1%
-69
+40.3%
-115
-659.7%
-15
Other income (expense)
-9
-166.6%
18
+86.7%
10
+24.4%
8
+163.8%
3
-29.6%
4
+249.4%
-3
Pretax income
-164
-217.5%
124
+72.8%
72
+432.4%
-22
+67.2%
-66
+40.7%
-111
—
Income tax
-22
+60.3%
-4
+91.8%
-54
-2850.7%
2
+6471.0%
-0
+99.0%
-3
—
Net income
-142
-173.4%
128
+1.8%
126
+635.3%
-24
+64.1%
-66
+39.0%
-108
-494.3%
-18
Basic EPS
-0.62
-170.8%
0.57
-1.7%
0.58
+627.3%
-0.11
+65.6%
-0.32
+44.8%
-0.58
—
Diluted EPS
-0.57
-173.0%
0.51
-3.8%
0.53
+581.8%
-0.11
+65.6%
-0.32
+44.8%
-0.58
—
Weighted average shares, basic
228
+3.6%
225
+4.2%
216
+3.1%
209
+2.4%
205
+9.5%
187
—
Weighted average shares, diluted
247
+0.4%
258
+9.0%
237
+13.1%
209
+2.4%
205
+9.5%
187
—
Other measures
Depreciation and amortization
87
+198.8%
55
+218.9%
17
+79.6%
10
+27.3%
7
+83.4%
4
—
EBITDA
-67
-143.5%
160
+102.7%
79
+496.2%
-20
+67.4%
-61
+44.8%
-111
—
Margins
Gross margin
68.43%
73.84%
79.45%
81.99%
77.57%
75.22%
—
Operating margin
-5.99%
4.50%
4.19%
-3.38%
-13.04%
-42.31%
—
Pretax margin
-6.35%
5.28%
4.86%
-2.47%
-12.47%
-40.75%
—
Profit margin
-5.51%
5.47%
8.54%
-2.70%
-12.46%
-39.60%
—
EBITDA margin
-2.61%
6.82%
5.35%
-2.29%
-11.62%
-40.81%
—
Effective tax rate
—
-3.58%
-75.76%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
HIMS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1773751
Former names
Oaktree Acquisition Corp. (until Jan 19, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

All 12 Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.